IL-2 activated killer cell activity is associated with the early phase of allograft rejection
Kamholz, S.; Roslin, M.; Mondragon, M.; Coons, M.; Tranbaugh, R.; Strashun, A.; Manjoney, D.; Norin, A.
Transplantation Proceedings 23(1 Part 1): 597-598
1991
ISSN/ISBN: 0041-1345 PMID: 1990620 Document Number: 386174
Document emailed within 1 workday
Related Documents
Jíra, M.; Malkovský, M.; Denman, A.M.; Loveland, B.; Lyons, D.; Dalgleish, A.G.; Webster, A.D. 1987: Lymphokine-activated killer cell activity in rheumatoid arthritis Clinical and Experimental Immunology 68(3): 535-542Tani, M.; Tanimura, H.; Yamaue, H.; Tsunoda, T.; Iwahashi, M.; Noguchi, K.; Tamai, M.; Hotta, T.; Mizobata, S. 1993: Augmentation of lymphokine-activated killer cell activity by lentinan Anticancer Research 13(5c): 1773-1776
Chao, T.Y.; Hwang, W.S.; Yeh, M.Y. 1995: Generation of lymphokine-activated killer (LAK) cell activity from malignant peritoneal effusions Proceedings of the National Science Council Republic of China. Part B Life Sciences 19(2): 92-98
Silver, R.M. 1990: Lymphokine activated killer (LAK) cell activity in the peripheral blood lymphocytes of systemic sclerosis (SSc) patients Clinical and Experimental Rheumatology 8(5): 481-486
Itoh, K.; Tilden, A.B.; Kumagai, K.; Balch, C.M. 1985: Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells Journal of Immunology 134(2): 802-807
Long, G.S.; Cramer, D.V.; Harnaha, J.B.; Hiserodt, J.C. 1990: Lymphokine-activated killer (LAK) cell purging of leukemic bone marrow: range of activity against different hematopoietic neoplasms Bone Marrow Transplantation 6(3): 169-177
Van de Griend, R.J.; van Krimpen, B.A.; Ronteltap, C.P.; Bolhuis, R.L. 1984: Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells Journal of Immunology 132(6): 3185-3191
Lamers, H.J.; Gratama, J.W.; van Putten, W.L.; Stoter, G.; Bolhuis, R.L. 1991: Exogenous interleukin 2 recruits in vitro lymphokine-activated killer activity by in vivo activated lymphocytes Cancer Research 51(9): 2324-2328
Houchins, J.P.; Lanier, L.L.; Niemi, E.C.; Phillips, J.H.; Ryan, J.C. 1997: Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C Journal of Immunology 158(8): 3603-3609
Stewart, J.A.; Belinson, J.L.; Moore, A.L.; Dorighi, J.A.; Grant, B.W.; Haugh, L.D.; Roberts, J.D.; Albertini, R.J.; Branda, R.F. 1990: Phase i trial of intraperitoneal recombinant interleukin-2/lymphokine-activated killer cells in patients with ovarian cancer Cancer Research 50(19): 6302-6310
Savas, B.; Kerr, P.E.; Ustun, H.; Cole, S.P.; Pross, H.F. 1998: Lymphokine-activated killer cell susceptibility and multidrug resistance in small cell lung carcinoma Anticancer Research 18(6a): 4355-4361
Coburn, R.J.; Nathan, P.; Ballantyne, D.L. 1971: Platelet activity in allograft rejection Surgical Forum 22: 476-478
Woodle, E.S.; Xu, D.; Zivin, R.A.; Auger, J.; Charette, J.; O'Laughlin, R.; Peace, D.; Jollife, L.K.; Haverty, T.; Bluestone, J.A.; Thistlethwaite, J.R. 1999: Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection Transplantation 68(5): 608-616
Berens, E.S.; Shelton, M.W.; Walp, L.A.; Basler, J.T.; Hanto, D.W. 1989: Survival of cytotoxic T-cell clones (Tc) in vivo and their ability to effect skin allograft rejection in T-cell depleted mice Transplantation Proceedings 21(1 Part 1): 138-139
Merion, R.M.; White, D.J.; Calne, R.Y. 1983: Early renal allograft rejection episodes are less aggressive with cyclosporin-A immunosuppression Transplantation Proceedings 15(4): 2172-2177
Ueda, K.; Baumgartner, W.A.; Beschorner, W.E.; Borkon, M.A.; Soule, L.M.; Reitz, B.R.; Herskowitz, A. 1985: Histologic pattern of early heart allograft rejection under cyclosporine treatment Journal of Heart Transplantation 4(3): 296-301
Rigby, R.J.; Smillie, A.; Cheung, K.; Robinson, M.F. 1985: Natural killer activity in renal allograft recipients and response to interferon Transplantation Proceedings 17(2): 1682-1684
Liu, G.R. 1993: Cytotoxicity of human lymphokine-activated killer cells against mitotic phase tumor cells Zhonghua Yi Xue Za Zhi 73(9): 547-548; 576
Munn, S.R.; Perkins, J.D. 1990: Rapid T cell recovery after prophylactic ALG is associated with pancreas allograft rejection Transplantation Proceedings 22(2): 619
Finn, O.J.; Miceli, M.C. 1989: Effector T-cell repertoire selection in human allograft rejection Transplantation Proceedings 21(1 Pt 1): 346-348